RAMMURTI KAMBLE to Bortezomib
This is a "connection" page, showing publications RAMMURTI KAMBLE has written about Bortezomib.
Connection Strength
0.112
-
Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma. N Engl J Med. 2022 07 14; 387(2):132-147.
Score: 0.048
-
Bortezomib-Based Induction Is Associated with Superior Outcomes in Light Chain Amyloidosis Patients Treated with Autologous Hematopoietic Cell Transplantation Regardless of Plasma Cell Burden. Transplant Cell Ther. 2021 03; 27(3):264.e1-264.e7.
Score: 0.044
-
Enhanced antimyeloma cytotoxicity by the combination of arsenic trioxide and bortezomib is further potentiated by p38 MAPK inhibition. Leuk Res. 2010 Jan; 34(1):85-92.
Score: 0.020